FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to derivatives of benzothiazole of the general formula (I):
and their pharmaceutically acceptable acid-additive salts used as ligands of adenosine receptors and to a medicinal agent based on thereof. In compound of the general formula (I) R means phenyl, pyridine-2-yl, -C(O)-O-(lower)-alkyl, -C(O)-(lower)-alkyl, -C(O)-morpholinyl, -C(O)-NR'2, -(CH2)n-NR'2 or -(CH2)n-O-(lower)-alkyl; R' means hydrogen atom or (lower)-alkyl. Compounds can be used in treatment and prophylaxis of diseases mediated by adenosine receptors A2A and A1, for example, in Alzheimer's disease, some depressive states, toxicomania, Parkinson's disease.
EFFECT: valuable medicinal properties of compounds.
15 cl, 3 sch, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 2-AMINOBENZOTHIAZOLYLUREAS AS ADENOSINE MODULATORS | 2002 |
|
RU2311905C2 |
| DERIVATIVES OF BENZOTHIAZOLE AND MEDICAMENT BASED ON THEREOF | 2002 |
|
RU2293083C2 |
| BENZOTHIAZOLE DERIVATIVES | 2005 |
|
RU2382782C2 |
| DERIVATIVES OF BENZOTHIAZOLE AND MEDICINAL AGENT BASED ON THEREOF | 2002 |
|
RU2301232C2 |
| DERIVATIVES OF NICOTINE- OR ISONICOTINE-BENZOTHIAZOLE AND MEDICINAL AGENT | 2002 |
|
RU2294933C2 |
| BENZOTHIAZOLE DERIVATIVES | 2001 |
|
RU2251419C2 |
| 2-IMIDAZOBENZOTHIAZOLES AS LIGANDS OF ADENOSINE RECEPTOR | 2004 |
|
RU2340612C2 |
| BENZOTHIAZOLES | 2002 |
|
RU2293736C2 |
| BENZOTHIAZOLE DERIVATIVES AND THEIR APPLICATION IN TREATMENT OF DISEASES RELATED TO ADENOSINE A RECEPTORS | 2004 |
|
RU2348622C2 |
| BENZOTHIAZOL DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS | 2004 |
|
RU2351597C2 |
Authors
Dates
2007-03-20—Published
2002-11-09—Filed